Xu Jiandong
Transaction: 10/07/2025
BUY
Change
+1,000
Price
$1.33
Filing
04/29/2026
Type
BUY
Estrella Immunopharma, Inc.
ESLA • Biotechnology
$0.40
▲ +0.02 (+5.29%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$17.20M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak liquidity · 0.12Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:31 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.40
Change5.29%
Shares Out43.00M
Market Cap$17.20M
Enterprise Value$17.05M
52W Range0.68 - 3.15
Beta0.89
P/E-1.72
P/B-2.31
P/FCF-1.83
EV/EBITDA-1.74
EV/FCF-1.82
Price$0.40
Change5.29%
Shares Out43.00M
Market Cap$17.20M
Enterprise Value$17.05M
52W Range0.68 - 3.15
Beta0.89
P/E-1.72
P/B-2.31
P/FCF-1.83
EV/EBITDA-1.74
EV/FCF-1.82
Earnings Yield-58.22%
FCF Yield-54.56%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.12
Quick Ratio0.12
Volume15.83K
Avg Volume39.19K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0Weak liquidity · 0.12Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-10-21
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Xu Jiandong
Transaction: 09/22/2025
BUY
Change
+1,000
Price
$1.16
Filing
04/29/2026
Type
BUY
Xu Jiandong
Transaction: 09/11/2025
BUY
Change
+100
Price
$1.04
Filing
04/29/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Xu Jiandong | BUY | +1,000 | $1.33 | 10/07/2025 | 04/29/2026 |
| Xu Jiandong | BUY | +1,000 | $1.16 | 09/22/2025 | 04/29/2026 |
| Xu Jiandong | BUY | +100 | $1.04 | 09/11/2025 | 04/29/2026 |
| Jia Dengyao | OTHER | 0 | Not reported | 09/22/2025 | 10/01/2025 |
| Xu Jiandong | BUY | +490,796 | $0.81 | 10/30/2024 | 02/14/2025 |
| Xu Jiandong | BUY | +509,204 | $0.81 | 10/30/2024 | 02/14/2025 |
| Liu Cheng | BUY | +490,796 | $0.81 | 10/30/2024 | 02/14/2025 |
| Liu Cheng | BUY | +509,204 | $0.81 | 10/30/2024 | 02/14/2025 |
| Zhang Hong | OPTION | 0 | Not reported | 08/14/2024 | 08/23/2024 |
| Eureka Therapeutics, Inc. | OTHER | 0 | Not reported | 09/29/2023 | 10/10/2023 |
| Wu Fan | OTHER | 0 | Not reported | 09/29/2023 | 10/10/2023 |
| Wu Xuejun Janelle | OTHER | 0 | Not reported | 09/29/2023 | 10/10/2023 |
| Liu Cheng | SELL | 0 | Not reported | 09/29/2023 | 10/10/2023 |
| Xu Pei | OTHER | 0 | Not reported | 09/29/2023 | 10/10/2023 |
| Roberts Marsha | OTHER | 0 | Not reported | 09/29/2023 | 10/10/2023 |
| Xu Jiandong | SELL | 0 | Not reported | 09/29/2023 | 10/10/2023 |
| Owl Creek Asset Management, L.P. | SELL | -255,000 | $10.86 | 09/29/2023 | 10/05/2023 |
| Yang Weiguang | OTHER | 0 | Not reported | 09/29/2023 | 10/02/2023 |
| Twigg Weston | OTHER | 0 | Not reported | 09/29/2023 | 10/02/2023 |
| Li Jianwei | OTHER | 0 | Not reported | 09/29/2023 | 10/02/2023 |